Last $2.70 USD
Change Today +0.07 / 2.66%
Volume 282.5K
ATRS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 10:30 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul K. Wotton Ph.D.

Former Chief Executive Officer, President and Director, Antares Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 4 different industries.

See Board Relationships
54--
As of Fiscal Year 2013

Background*

Dr. Paul K. Wotton, Ph.D. has been Chief Executive Officer and President of Advanced Cell Technology Inc. since July 2014. Dr. Wotton served as the Chief Executive Officer of Antares Pharma Inc. since October 2008 until June 2014 and served as its President since July 2008 until June 2014. Dr. Wotton served as the Chief Executive Officer and President of Topigen Pharmaceuticals Inc. until March 2008. He served as Chief Operating Officer of Antares Pharma Inc. from July ...

Read Full Background

Corporate Headquarters*

100 Princeton South
Ewing, New Jersey 08628

United States

Phone: 609-359-3020
Fax: --

Board Members Memberships*

Former Chief Executive Officer, President and Executive Director
2004-2014
Former Chief Executive Officer, President and Director
2008-N/A
Director
2014-Present
Chief Executive Officer, President, Director and Member of Pricing Committee

Education*

Bachelor's Degree
University Of London
MBA
Kingston Business School
PhD
Nottingham University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $2.70 USD +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Olav Hellebo Chief Executive Officer
ReNeuron Group plc
--
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, General Counsel and Director
Neuralstem, Inc.
$651.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.